Real Quantum for a Post Classical World

Our vision

On the basis of our unique technologies, we are looking to bring the power of quantitative simulations to solve pressing problems in the pharmaceutical and chemistry spaces.

We are hiring!

As QSimulate is expanding the team, we have multiple open positions including scientists, software engineers, project management, and business development.
For software developer positions, please see more details at AngelList. For other positions, please write to us at hire@qsimulate.com for further inquiry.
Our offices are located in Boston MA and Berkeley CA, USA, and Ghent, Belgium.
QSimulate logo

Our People

Toru Shiozaki
Toru Shiozaki linkedin button

Chief Executive Officer
and Co-founder

David Pearlman
David Pearlman linkedin button

Vice President of Product

Trevor Barsamian
Trevor Barsamian linkedin button

Director of Business Development

Garnet Chan
Garnet Chan linkedin button

Chief Scientific Advisor
and Co-founder

Romanos Daniel
Romanos Daniel linkedin button

Chairman of the Advisory Board

Jia Chen
Jia Chen linkedin button

Head of Quantum Research

Alec White
Alec White linkedin button

Head of Algorithms

Alexander Doran
Alexander Doran linkedin button

Senior Software Engineer

Klaas Gunst
Klaas Gunst linkedin button

Branch Manager, Europe

Charlotte Ward
Charlotte Ward linkedin button

Operations Manager

Leon Freitag
Leon Freitag linkedin button

Senior Software Engineer

Zhenjun Hu
Zhenjun Hu linkedin button

Senior Software Engineer

Csaba Daday
Csaba Daday linkedin button

Senior Scientist

Fredy Aquino
Fredy Aquino linkedin button

Software Engineer

Sruthi Murlidaran
Sruthi Murlidaran linkedin button


Beatrice Van Der Goetz
Beatrice Van Der Goetz linkedin button


David Reilley
David Reilley linkedin button


Sebastien Hoyas
Sébastien Hoyas linkedin button


Daniel Moberg
Daniel Moberg linkedin button


Jaden Tayag
Jaden Tayag linkedin button

Junior Software Engineer


QSimulate expands collaboration with Google Quantum AI

QSimulate is expanding its partnership with Google Quantum AI while releasing the Fermionic Quantum Emulator (FQE). QSimulate and Google Quantum AI, leaders in the space, continue to seize on the increasing commercial engagement with quantum simulation and quantum computing.
(November 10th, 2021)
Google logo

Fermionic Quantum Emulator highlighted in the Google Open Source Blog

Fermionic Quantum Emulator (FQE), jointly developed by QSimulate and Google Quantum AI, has been highlighted in the Google Open Source Blog. FQE has enabled orders of magnitude faster emulation of quantum circuits for chemistry.
Check out the full article from the link below!
(November 4th, 2021)
Google logo

AWS partners with QSimulate for Healthcare and Life Sciences Program

AWS announces the Healthcare and Life Sciences Program, in which QSimulate has been chosen as one of its partners. Combining our technology and AWS's vast computing resources, we are enabling, for the first time, computational drug discovery using quantum mechanics. What would have taken weeks and months now only takes minutes. We look forward to further collaboration with AWS.
(May 25th, 2021)
Amazon logo

QSimulate technology enables groundbreaking advances in quantum mechanics/molecular mechanics (QM/MM) simulations for large protein modeling

A new publication from RIKEN has described a native integration of the highly efficient QSimulate-QM software and RIKEN’s GENESIS molecular dynamics (MD) program, achieving unprecedented throughput for the simulations of large protein reactions. High throughput suggests a broadened scope of applicability for QM/MM calculations going forward. Questions of drug discovery and materials development that have previously been beyond the reach of QM due to insufficient turnaround now appear to be within our grasp.
(April 29th, 2021)
RIKEN logo

QSimulate raises $5M to revolutionize pharmaceutical and materials R&D with quantum mechanics

QSimulate is excited to announce that we have closed a $5 million seed round to accelerate our efforts to revolutionize the impact of quantum-based simulations on drug discovery and materials development. We are expanding our product and business efforts, and we'll soon be announcing several opportunities to join our amazing team. Stay tuned!
Team members
(April 12th, 2021)
QSimulate logo
The National Institutes of Health (NIH) has announced the award of a research grant to QSimulate. The grant, “Scoring ligand/protein interactions using a novel high performance implementation of DFT quantum mechanics,” will fund efforts to integrate quantum mechanics into the process of drug discovery in a manner that was previously impossible. David A Pearlman, VP of Product at QSimulate, will serve as the Principal Investigator on the project.
(March 1st, 2021)
NIH logo
In a new publication, scientists at start-up QSimulate describe the application of a new and novel implementation of quantum mechanics (QM) to the question of how well various diverse drugs bind to SARS-CoV-2 Mpro, a protein required for the replication of COVID-19. The diversity in structure and formal charge of this set is large, rendering accurate scoring by traditional methods difficult or impossible. However, QSimulate has demonstrated that QM with high accuracy can successfully rank binding strength for this challenging set. The results suggest a broader path forward for the integration of QM in drug discovery.
(October 19th, 2020)
QSimulate logo
AWS made an announcement on the general availability of Amazon Braket, in which QSimulate's collaboration with Amgen was highlighted as a success of QSimulate as a launch partner of Amazon Quantum Solutions Lab.

...Yax Sun, Director and Narbe Mardirossian, Scientist, at Amgen. “By collaborating with the Amazon Quantum Solutions Lab and QSimulate, we’ve been able to quickly build and test a cloud-based approach using multiple compute resources on AWS for a critical drug discovery process—a process we plan to transition to a quantum computer in the future when it is practical. Looking ahead, Amazon Braket has the potential to substantially benefit the research and scientific community by providing on-demand access to quantum computing technologies and accelerate innovation in biotechnology.

(August 14th, 2020)

Amgen logo

Amazon logo

The QSimulate quantum simulation platform that enables unprecedented high throughput, QSimulate-MI, has been enlisted by JSR Corporation, one of the major players in the display, semiconductor, optical, and polymer materials market, to enable the discovery of novel materials using Materials Informatics (MI) approaches. In this partnership, QSimulate has provided JSR access to its unique automated QM tools on the cloud, making it possible to run high accuracy quantum calculations for thousands of molecules on a daily basis. This, in turn, provides a superior dataset for Materials Informatics, as well as the ability to efficiently supplant that training set as required.
(July 2nd, 2020)
JSR logo
Quantum-based startup QSimulate has announced a collaboration with Amgen focused on integrating large scale, high accuracy, quantum mechanics calculations (QM) into the drug discovery pipeline. The impetus for the new collaboration is the development by QSimulate of a novel implementation of density functional theory, a variant of QM, that allows these calculations to be run with discovery-relevant throughput on realistic ligand/protein models for the first time by taking full advantage of cloud resources.
(April 21st, 2020)
Amgen logo
QSimulate is pleased to announce delivery of phases I and II of its contract with Google AI Quantum Lab.
"We are very happy to partner with QSimulate, a leading developer of HPC based quantum software, as we move towards products for the emerging quantum market", says Ryan Babbush, Head of Quantum Algorithms at Google Quantum. "Our partnership with Google further advances our position in this area and will open up new audiences for our unique technologies", says Toru Shiozaki, CEO of QSimulate.
(April 2nd, 2020)
Google logo
QSimulate has been selected among the few launching partners of Amazon Quantum Solution Lab as a pioneer in the quantum mechanical simulations space.
The Amazon Quantum Solutions Lab connects customers with quantum computing experts from Amazon and its technology and consulting partners to help discover new applications and find ways to apply quantum computing inside their organizations. As the technology eventually reaches the point of commercial viability, AWS and its partners will collaborate on experiments with customers and guide them to incorporate quantum solutions into their business. Among other launching partners are 1Qbit, Rahko, Rigetti, QCWare, Xanadu, and Zapata.
(December 2nd, 2019. Link)
Amazon logo

About Us

We are an international team based in Boston and Berkeley, USA, and Ghent, Belgium.
For questions and inquiries, please write to us at info@qsimulate.com

Boston, MA
Berkeley, CA
Ghent, Belgium